Lifevantage (LFVN)
(Delayed Data from NSDQ)
$6.19 USD
-0.06 (-0.88%)
Updated Apr 26, 2024 03:50 PM ET
After-Market: $6.19 +0.01 (0.08%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Lifevantage Corporation falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 213 | 206 | 220 | 233 | 226 |
Cost Of Goods | 43 | 38 | 38 | 38 | 38 |
Gross Profit | 170 | 168 | 182 | 195 | 188 |
Selling & Adminstrative & Depr. & Amort Expenses | 166 | 161 | 164 | 179 | 178 |
Income After Depreciation & Amortization | 4 | 8 | 18 | 15 | 10 |
Non-Operating Income | 0 | -3 | 0 | -1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 4 | 5 | 17 | 15 | 9 |
Income Taxes | 1 | 2 | 4 | 3 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 3 | 3 | 13 | 12 | 7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 3 | 3 | 13 | 12 | 7 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 8 | 13 | 23 | 21 | 12 |
Depreciation & Amortization (Cash Flow) | 4 | 5 | 6 | 5 | 2 |
Income After Depreciation & Amortization | 4 | 8 | 18 | 15 | 10 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 12.57 | 13.07 | 14.27 | 14.60 | 14.98 |
Diluted EPS Before Non-Recurring Items | 0.24 | 0.41 | 1.00 | 0.86 | 0.59 |
Diluted Net EPS (GAAP) | 0.20 | 0.24 | 0.90 | 0.79 | 0.50 |
Fiscal Year end for Lifevantage Corporation falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 51.62 | 51.36 | 54.22 | 53.74 |
Cost Of Goods | NA | 11.07 | 10.18 | 11.07 | 10.62 |
Gross Profit | NA | 40.56 | 41.18 | 43.15 | 43.12 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 41.82 | 40.44 | 40.55 | 41.52 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.26 | 0.74 | 2.60 | 1.60 |
Non-Operating Income | NA | 0.15 | 0.08 | -0.15 | 0.01 |
Interest Expense | NA | 0.00 | 0.00 | -0.11 | -0.06 |
Pretax Income | NA | -1.11 | 0.83 | 2.56 | 1.67 |
Income Taxes | NA | -0.46 | 0.20 | 0.59 | 0.64 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.66 | 0.63 | 1.97 | 1.02 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.66 | 0.63 | 1.97 | 1.02 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 12.61 | 13.11 | 12.98 | 12.77 |
Diluted EPS Before Non-Recurring Items | NA | 0.10 | 0.13 | 0.17 | 0.08 |
Diluted Net EPS (GAAP) | NA | -0.05 | 0.05 | 0.15 | 0.08 |